A detailed history of Strategic Investment Advisors transactions in Abbott Laboratories stock. As of the latest transaction made, Strategic Investment Advisors holds 7,526 shares of ABT stock, worth $784,359. This represents 0.11% of its overall portfolio holdings.

Number of Shares
7,526
Previous 7,259 3.68%
Holding current value
$784,359
Previous $798,000 7.14%
% of portfolio
0.11%
Previous 0.12%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 22, 2024

BUY
$109.52 - $120.96 $29,241 - $32,296
267 Added 3.68%
7,526 $855,000
Q4 2023

Jan 10, 2024

SELL
$90.19 - $110.4 $59,074 - $72,312
-655 Reduced 8.28%
7,259 $798,000
Q3 2023

Oct 24, 2023

SELL
$95.53 - $114.62 $16,526 - $19,829
-173 Reduced 2.14%
7,914 $766,000
Q2 2023

Aug 14, 2023

BUY
$100.78 - $112.29 $94,632 - $105,440
939 Added 13.14%
8,087 $881,000
Q1 2023

Apr 27, 2023

SELL
$96.86 - $114.01 $638,501 - $751,553
-6,592 Reduced 47.98%
7,148 $723,000
Q4 2022

Jan 19, 2023

BUY
$95.06 - $111.52 $240,311 - $281,922
2,528 Added 22.55%
13,740 $0
Q3 2022

Oct 27, 2022

SELL
$96.76 - $112.03 $5,805 - $6,721
-60 Reduced 0.53%
11,212 $1.09 Million
Q2 2022

Aug 15, 2022

SELL
$102.07 - $123.37 $10,921 - $13,200
-107 Reduced 0.94%
11,272 $1.23 Million
Q1 2022

Apr 28, 2022

SELL
$114.02 - $139.04 $28,390 - $34,620
-249 Reduced 2.14%
11,379 $1.35 Million
Q4 2021

Jan 26, 2022

BUY
$115.53 - $141.46 $6,585 - $8,063
57 Added 0.49%
11,628 $1.64 Million
Q3 2021

Oct 19, 2021

BUY
$116.66 - $129.06 $87,844 - $97,182
753 Added 6.96%
11,571 $1.37 Million
Q2 2021

Jul 22, 2021

BUY
$105.79 - $124.53 $315,148 - $370,974
2,979 Added 38.0%
10,818 $1.25 Million
Q1 2021

Apr 14, 2021

BUY
$108.84 - $128.23 $76,623 - $90,273
704 Added 9.87%
7,839 $939,000
Q4 2020

Jan 13, 2021

BUY
$105.0 - $114.42 $108,255 - $117,967
1,031 Added 16.89%
7,135 $781,000
Q3 2020

Oct 14, 2020

BUY
$91.64 - $111.29 $79,910 - $97,044
872 Added 16.67%
6,104 $664,000
Q2 2020

Aug 04, 2020

BUY
$76.57 - $98.0 $27,794 - $35,574
363 Added 7.46%
5,232 $478,000
Q1 2020

Apr 13, 2020

BUY
$62.82 - $91.86 $99,820 - $145,965
1,589 Added 48.45%
4,869 $384,000
Q4 2019

Jan 23, 2020

SELL
$78.51 - $87.4 $157 - $174
-2 Reduced 0.06%
3,280 $285,000
Q3 2019

Oct 25, 2019

BUY
$81.84 - $88.74 $1,636 - $1,774
20 Added 0.61%
3,282 $275,000
Q2 2019

Jul 23, 2019

BUY
$72.88 - $85.0 $237,734 - $277,270
3,262 New
3,262 $274,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $183B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Strategic Investment Advisors Portfolio

Follow Strategic Investment Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strategic Investment Advisors , based on Form 13F filings with the SEC.

News

Stay updated on Strategic Investment Advisors with notifications on news.